Loading clinical trials...
Loading clinical trials...
The objective of this post-approval registry is to provide additional real-world evidence of the performance of the OCS Heart System to preserve DBD and DCD donor hearts.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
TransMedics
NCT03000244 · Hematopoietic Stem Cell Transplantation, Tissue Donors
NCT07569055 · Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
NCT05753930 · Kidney Transplantation in Highly Sensitized Patients
NCT06861257 · Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, and more
NCT05579639 · Allogeneic Stem Cell Transplantation
Cedars Sinai
Los Angeles, California
Stanford University
Palo Alto, California
University of California San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions